ClinicalTrials.gg
Sign In

Atrophy clinical trials

The registry lists 125 studies for Atrophy across more than 10 countries. 21 are recruiting or about to start. 41 of them are mainly about Atrophy (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27.

Get an email when these change. Save the Atrophy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
71
Status unknown
21
Recruiting
13
Not yet recruiting
7
Active, not recruiting
5
Terminated
3

Phase

Phase 3
14
Phase 2
13
Phase 1
7
Phase 4
4
Early Phase 1
2

Where

United States
29
France
15
Italy
10
Spain
10
Germany
10
United Kingdom
8

Who runs them

Shionogi (6) · Cairo University (4) · Federal University of São Paulo (3) · Scholar Rock, Inc. (3) · University of Erlangen-Nürnberg Medical School (2) · Maastricht University Medical Center (2) · University of Pittsburgh (2) · Hacettepe University (2)

What is being tested here

Drugs under test in Atrophy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Oxytocin112
Metformin101
Beta-hydroxyisovaleric acid101
Ospemifene056
Apitegromab023
Estradiol012
Leucine002
Nitrates001
Bimagrumab001
Clobetasol001

Coming up

3phase 3 studies under way
7studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 13 Atrophy studies recruiting now, 4 (31%) set no upper age limit and 4 (31%) stop at 75 or younger. 0 (0%) take children under 18. 3 (23%) are for women only and 0 (0%) for men only; 6 (46%) take healthy volunteers.

Recruiting studies that take each age, of 13
AgeWomenMen
100 (0%)0 (0%)
186 (46%)5 (38%)
308 (62%)6 (46%)
408 (62%)6 (46%)
507 (54%)6 (46%)
6510 (77%)9 (69%)
7510 (77%)9 (69%)
856 (46%)6 (46%)

Across all 125 studies, recruiting or not: 37% stop at 75 or younger and 23% at 65; 8% take children; 19% are for women only and 6% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Atrophy studies take

Of 49 interventional studies with no phase under Atrophy, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo9–37 · 49 studies—13 mo8–37 · 43 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 125. Browse all 125 → or search them.